Infigratinib
Infigratinib (BGJ398) is an orally bioavailable pan FGFR inhibitor (IC50: 0.9/1.4/1 nM for FGFR1/2/3), >40-fold selective for FGFR versus FGFR4 and VEGFR2.
| Catalog Number | T1975 |
| Alternative Name(s) | BGJ-398 , NVP-BGJ398 |
| Research Area | Tyrosine Kinase/Adaptors|||Angiogenesis|||Apoptosis |
| Molecular Formula | C26H31Cl2N7O3 |
| CAS# | 872511-34-7 |
| Purity | 98.03% |
| SMILES | CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)cc1 |
| Size | 5 mg |
| Supplier Page | https://www.targetmol.com/compound/Infigratinib |
| Additional Information | https://www.targetmol.com/datasheet/T1975 |
